Rep. Carter: FDA Drops Plan That Would Reduce Patient Access to Compounded Drugs
February 24, 2022
February 24, 2022
WASHINGTON, Feb. 24 -- Rep. Buddy Carter, R-Georgia, issued the following news release:
Following Republican and stakeholder opposition, the federal government dropped its plan that would have restricted patients' access to lifesaving medications.
The Food and Drug Administration (FDA) announced today that it is rescinding a controversial memorandum of understanding (MOU) requiring states to either adopt a burdensome, poorly crafted policy targeting drug compounder . . .
Following Republican and stakeholder opposition, the federal government dropped its plan that would have restricted patients' access to lifesaving medications.
The Food and Drug Administration (FDA) announced today that it is rescinding a controversial memorandum of understanding (MOU) requiring states to either adopt a burdensome, poorly crafted policy targeting drug compounder . . .